About Affymax (OTCMKTS:AFFY)
Affymax, Inc. is a biopharmaceutical company. The Company's product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company's product, OMONTYS.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Affymax (OTCMKTS:AFFY) Frequently Asked Questions
What is Affymax's stock symbol?
Affymax trades on the OTCMKTS under the ticker symbol "AFFY."
Who are some of Affymax's key competitors?
Some companies that are related to Affymax include Sabine Oil & Gas (SOGCQ), TearLab (TEAR), Bon-Ton Stores (BONT), Republic Airways (RJETQ), Cardinal Energy Group (CEGX), KiOR (KIORQ), FunctionX (FNCX), OmniTek Engineering (OMTK), Horsehead (ZINCQ), Inventergy Global (INVT), Excel Maritime Carriers (EXMCQ), Digiliti Money Group (DGLT), Alpha Natural Resources (ANRZQ), Blue Ridge Mountain Resources (MHRCQ), Towerstream (TWER), GSE (GSEH), Atlas Resource Partners (ARPJQ) and BG Medicine (BGMD).
Who are Affymax's key executives?
Affymax's management team includes the folowing people:
- John A. Orwin, Independent Chairman of the Board
- Jonathan M. Couchman, President, Chief Executive Officer, Director
- Mark G. Thompson, Chief Financial Officer
- Grace U. Shin J.D., General Counsel
How do I buy Affymax stock?
Shares of Affymax can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Affymax's stock price today?
One share of Affymax stock can currently be purchased for approximately $0.03.
How big of a company is Affymax?
Affymax has a market capitalization of $970,000.00.
How can I contact Affymax?
Affymax's mailing address is 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014. The biopharmaceutical company can be reached via phone at 650-812-8700 or via email at [email protected]
MarketBeat Community Rating for Affymax (AFFY)MarketBeat's community ratings are surveys of what our community members think about Affymax and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Affymax (OTCMKTS:AFFY) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Affymax (OTCMKTS:AFFY) Earnings History and Estimates Chart
Affymax (OTCMKTS AFFY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/31/2014||Q2 2014||$0.19||$0.04 million||View||N/A|
|8/5/2013||Q2 2013||$0.12||$0.53 million||View||N/A|
|5/9/2013||Q113||($0.66)||($0.71)||$63.20 million||$0.84 million||View||N/A|
|4/2/2013||Q4 2012||($0.61)||($1.85)||$14.81 million||$14.77 million||View||N/A|
|11/8/2012||Q312||($0.70)||($0.68)||$13.41 million||$13.60 million||View||N/A|
Affymax (OTCMKTS:AFFY) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Affymax (OTCMKTS:AFFY)
No dividend announcements for this company have been tracked by MarketBeat.com
Affymax (OTCMKTS AFFY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.55%
Affymax (OTCMKTS AFFY) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/28/2013||John Peter Walker||Director||Sell||16,540||$1.92||$31,756.80|| |
Affymax (OTCMKTS AFFY) News Headlines
Affymax (OTCMKTS:AFFY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Affymax (OTCMKTS:AFFY) Income Statement, Balance Sheet and Cash Flow Statement
Affymax (OTCMKTS AFFY) Stock Chart for Tuesday, February, 20, 2018